Glycoproteins (e.g., Hormone, Etc.) Patents (Class 436/87)
-
Publication number: 20130316463Abstract: A method of purifying a glycan and/or a glycoconjugate comprising the steps of: (a) providing a stationary phase that comprises cotton; (b) applying a glycan and/or glycoconjugate-containing sample to the stationary phase; (c) washing the stationary phase with a first solvent; and (d) eluting the glycan and/or glycoconjugate from the stationary phase with a second solvent. A kit for purifying a glycan and/or glycoconjugate, the kit comprising: a stationary phase comprising cotton; and instructions for purifying a glycan and/or glycoconjugate according to the disclosed method.Type: ApplicationFiled: February 10, 2012Publication date: November 28, 2013Applicants: F. HOFFMAN-LA ROCHE AG, LEIDEN UNIVERSITY MEDICAL CENTERInventors: Manfred Wuhrer, Mahdi Hemayatkar, Maurice Henricus Johannes Selman
-
Publication number: 20130310546Abstract: The invention relates to materials and methods of conjugating a water soluble polymer to an oxidized carbohydrate moiety of a therapeutic protein comprising contacting the oxidized carbohydrate moiety with an activated water soluble polymer under conditions that allow conjugation and analyzing the conjugation using 2D NMR analysis. More specifically, the present invention relates to the aforementioned materials and methods wherein the water soluble polymer contains an active aminooxy group and wherein an oxime or hydrazone linkage is formed between the oxidized carbohydrate moiety and the active aminooxy group on the water soluble polymer, and wherein the conjugation is carried out in the presence of a nucleophilic catalyst.Type: ApplicationFiled: March 14, 2013Publication date: November 21, 2013Inventors: G. Joseph Ray, Zhenqing Zhang, Christina Szabo, Juergen Siekmann, Richard Scheinecker, Stefan Haider, Hanspeter Rottensteiner, Paul Kosma
-
Publication number: 20130303732Abstract: The invention provides a method for controlling contaminants in biopharmaceutical purification processes by using light scattering and UV absorbance to establish a determinant. The invention makes use of multi-angle light scattering (MALS) and UV as a continuous monitoring system to provide information about the elution peak fractions in real-time instead of conventional pooling methods that rely on a predetermined percent UV peak max value to initiate the pooling process; regardless of product quality.Type: ApplicationFiled: March 26, 2013Publication date: November 14, 2013Inventors: Arthur C. Hewig, III, Duke H. Phan, Yinges Yigzaw, Robert Bailey
-
Patent number: 8580491Abstract: The present invention relates to a method for diagnosing cancer using information on the aberrant glycosylation of a glycoprotein. More precisely, the present invention relates to a cancer diagnosis peptide marker, which is screened by: a step of separating, using a lectin, a glycoprotein which is aberrantly glycosylated in accordance with the occurrence of cancer; and a step of selecting a hydrolyzed peptide marker derived from the aberrantly glycosylated glycoprotein by observing the quantitative changes in the separated glycoprotein. The present invention also relates to a method for diagnosing cancer using the peptide marker as an agent.Type: GrantFiled: December 24, 2010Date of Patent: November 12, 2013Assignee: Korea Basic Science InstituteInventors: Yeong Hee Ahn, Jong Shin Yoo
-
Patent number: 8557978Abstract: This invention provides cross-linked glycopeptide-cephalosporin compounds and pharmaceutically acceptable salts thereof which are useful as antibiotics. This invention also provides pharmaceutical compositions containing such compounds; methods for treating bacterial infections in a mammal using such compounds; and processes and intermediates useful for preparing such compounds.Type: GrantFiled: September 21, 2011Date of Patent: October 15, 2013Assignee: Theravance, Inc.Inventor: Daniel D. Long
-
Patent number: 8541245Abstract: The present invention provides methods and kits for assessing the state of oocyte maturation in a female mammal based on the level of PAPP-A found in the female's bodily fluid sample.Type: GrantFiled: June 11, 2010Date of Patent: September 24, 2013Assignee: Beckman Coulter, Inc.Inventor: William E. Roudebush
-
Publication number: 20130244263Abstract: The invention is directed to a method of identifying a patient undergoing periodic hemodialysis treatments at increased risk for death that includes determining at least one of the patient's clinical or biochemical parameters, consisting of serum bicarbonate concentration level, serum potassium concentration level, serum calcium concentration level, hemoglobin concentration level, serum phosphorus concentration level, neutrophil to lymphocyte ratio, equilibrated normalized protein catabolic rate (enPCR), equilibrated fractional clearance of total body water by dialysis and residual kidney function (eKdrt/V), EPO resistance index, transferrin saturation index, serum ferritin concentration level, serum creatinine concentration level, platelet count, Aspartat-Aminotransferase level, and Alanin-Aminotransferase level at periodic hemodialysis treatments, and identifying a patient as having an increased risk for death if the patient has a significant change in the rate of change of at least one of the patient's cliType: ApplicationFiled: December 1, 2011Publication date: September 19, 2013Inventors: Peter Kotanko, Stephan Thijssen, Len Usvyat, Nathan W. Levin
-
Publication number: 20130183762Abstract: A method for detecting adrenocorticotropic hormone comprising: bringing a liquid sample containing adrenocorticotropic hormone into contact with gelled casein to adsorb adrenocorticotropic hormone to the gelled casein; and detecting the adrenocorticotropic hormone adsorbed to the gelled casein is disclosed. An adsorbent of adrenocorticotropic hormone comprising gelled casein is also disclosed.Type: ApplicationFiled: January 11, 2013Publication date: July 18, 2013Applicant: SYSMEX CORPORATIONInventor: Sysmex Corporation
-
Patent number: 8486705Abstract: The invention provides methods and apparatus for characterizing complex polymeric mixture of interest. Candidate solutions are eliminated from a solution space using one or more experimental measurements of a polymeric mixture of interest. The elimination step can be repeated one or more times using different experimental measurements produced by various chemical and physical protocols, so that the remaining candidate solutions converge to describe the actual polymeric mixture under investigation. Once the composition of the complex polymeric mixture has been characterized, the information thus generated can be used to facilitate, for example, the manufacture of a bio-equivalent of the complex polymeric mixture.Type: GrantFiled: March 20, 2012Date of Patent: July 16, 2013Assignee: Momenta Pharmaceuticals, Inc.Inventor: Sasisekharan Raguram
-
Publication number: 20130177933Abstract: The present specification discloses methods of characterizing a population of particles using a particle analyzer. Particles may be characterized by size, absolute number, whether the particle is non-proteinaceous or proteinaceous, whether a proteinaceous particle has or lacks a certain physical property, or any combination thereof.Type: ApplicationFiled: January 11, 2013Publication date: July 11, 2013Applicants: Baxter Healthcare SA, Baxter Healthcare CorporationInventors: Baxter Healthcare Corporation, Baxter Healthcare SA
-
Patent number: 8476077Abstract: Disclosed is use of urine and serum biomarkers in diagnosing diabetic nephropathy, staging diabetic nephropathy, monitoring diabetic nephropathy progress, and assessing efficacy of diabetic nephropathy treatments. These biomarkers include urine precursor alpha-2-HS-glycoprotein, urine alpha-1 antitrypsin, urine alpha-1 acid glycoprotein, urine osteopontin, serum osteopontin, their fragments, and combinations thereof.Type: GrantFiled: December 15, 2010Date of Patent: July 2, 2013Assignee: Industrial Technology Research InstituteInventors: Wei-Ya Lin, Mary Ya-Ping Yeh, Tzu-Ling Tseng, Ping-Fu Cheng, Tsai-Wei Hsu, Hung-Yi Li, Yi-Ting Chen, Yuh-Feng Ling, Jin-Shuen Chen, Yen-Peng Li
-
Patent number: 8476074Abstract: A method for detecting a predisposition to breast cancer in a subject is provided. The method includes detecting in a biological sample from the subject one or more polymorphisms in the sequence of CD44 gene. The presence of one or more polymorphisms in the sequence of CD44 gene indicates that the subject has a predisposition for developing breast cancer.Type: GrantFiled: January 7, 2013Date of Patent: July 2, 2013Assignee: University of South CarolinaInventors: Juhua Zhou, Mitzi Nagarkatti, Prakash Nagarkatti
-
Patent number: 8465980Abstract: Disclosed is use of urine and serum biomarkers in diagnosing diabetic nephropathy, staging diabetic nephropathy, monitoring diabetic nephropathy progress, and assessing efficacy of diabetic nephropathy treatments. These biomarkers include urine precursor alpha-2-HS-glycoprotein, urine alpha-1 antitrypsin, urine alpha-1 acid glycoprotein, urine osteopontin, serum osteopontin, their fragments, and combinations thereof.Type: GrantFiled: January 27, 2010Date of Patent: June 18, 2013Assignee: Industrial Technology Research InstituteInventors: Wei-Ya Lin, Mary Ya-Ping Yeh, Tzu-Ling Tseng, Ping-Fu Cheng, Tsai-Wei Hsu, Hung-Yi Li, Yi-Ting Chen, Yuh-Feng Ling, Jin-Shuen Chen, Yen-Peng Li
-
Patent number: 8455265Abstract: A surface grafted conjugated polyelectrolyte (CPE) is formed by coupling a CPE by a coupling moiety to the surface of a substrate. The substrate can be of any shape and size, and for many uses of the surface grafted CPE, it is advantageous that the substrate is a nanoparticle or microparticle. Surface grafted CPEs are presented that use silica particles as the substrate, where a modified silane coupling agent connects the surface to the CPE by a series of covalent bonds. Two methods of preparing the surface grafted CPEs are presented. One method involves the inclusion of the surface being modified by the coupling agent and condensed with monomers that form the CPE in a grafted state to the substrate. A second method involves the formation of a CPE with terminal groups that are complimentary to functionality that has been placed on the surface of the substrate by reaction with a coupling agent. The surface grafted CPEs are also described for use as biosensors and biocides.Type: GrantFiled: February 29, 2008Date of Patent: June 4, 2013Assignee: STC.UNMInventors: David G. Whitten, Sireesha Chemburu, Thomas Corbitt, Linnea Ista, Gabriel Lopez, Kirk S. Schanze, Motokatsu Ogawa, Eunkyung Ji
-
Patent number: 8440465Abstract: A method for analyzing chemicals includes fractionating a complex sample into at least two sample portions that each include portions of two polypeptides though in different concentration ratios, digesting and performing LC/MS on each of the sample portions, and associating precursor ions observed via LC/MS with their corresponding polypeptide in response to LC/MS-provided intensity data. A set of precursor-ions that has substantially similar intensity ratios in both sample portions is determined to be associated with the same polypeptide.Type: GrantFiled: February 24, 2012Date of Patent: May 14, 2013Assignee: Waters Technologies CorporationInventors: Marc V. Gorenstein, Scott J. Geromanos, Jeffrey Cruz Silva, Guo-Zhong Li
-
Patent number: 8440464Abstract: Provided is a method for conveniently and rapidly evaluating or selecting an adiponectin secretion regulator. The method for evaluating or selecting an adiponectin secretion regulator includes the following steps (A) to (C): (A) a step of administering a test substance to an experimental animal; (B) a step of inducing a sleep deprivation in the experimental animal; and (C) a step of measuring blood adiponectin level of the animal, and evaluating change of the blood adiponectin level.Type: GrantFiled: April 14, 2009Date of Patent: May 14, 2013Assignee: Kao CorporationInventor: Akihiko Fujii
-
Patent number: 8431405Abstract: The present invention related to a pregnancy test device that can selectively detect hyperglycosylated human chorionic gonadotropin (hCG-H) in a liquid sample. The sample can be deposited on a proximal portion of the device for transport to a distal portion of the device. The device can include a release medium formed of a first material and including a detectable label thereon and a capture medium, including a capture site, in fluid communication with the release medium and formed of a second, different material. At least one of the release medium and the capture medium includes a binding member that exhibits a moderate to high affinity for hCG-H and is selectively or preferentially reactive with hCG-H.Type: GrantFiled: August 22, 2012Date of Patent: April 30, 2013Assignee: Church & Dwight Co., Inc.Inventors: Albert R. Nazareth, Timothy Snowden
-
Patent number: 8421485Abstract: A particle detection device (10) included substrates (1, 4), insulating members (2, 3), supporting member (5), and electrodes (6, 7). The insulating member (2) is provided on a principal surface of the substrate (1) and has a recess. The insulating member (3) is provided so as to make contact with the insulating member (3) and the substrate (4). The substrate (4) is formed on a principal surface of the supporting member (5). The electrode (6) is formed on a surface, which is opposite to the surface where the insulating member (2) is formed, of the substrate (1). The electrode (7) is formed on the surface (5A), the side surface (5B), and the rear surface (5C) of the supporting member (5) so as to be connected to the substrate (4). Accordingly, the detection device 10 includes a gap (8) surrounded by the insulating members (2, 3). The substrate (1) is connected to the substrate (4) with the insulating members (2, 3) and the supporting member (5) (quartz).Type: GrantFiled: December 13, 2007Date of Patent: April 16, 2013Inventors: Mizuho Morita, Takaaki Hirokane
-
Publication number: 20130090550Abstract: Methods for identifying patients with ovarian neoplasms are provided herein comprising performing an assay step of detecting a metabolite in a serum sample of a patient where the metabolite is probably not produced by a tumor but could induce the development of a tumor, and the presence of the metabolite being indicative of an increased likelihood that the patient has ovarian cancer,Type: ApplicationFiled: June 9, 2011Publication date: April 11, 2013Applicant: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEMInventors: Elvio G. Silva, Cristina Fente Sampayo
-
Publication number: 20130045501Abstract: A detection device for detecting analytes in liquid specimen is provided. The detection device comprises: a specimen chamber for collecting or storing a liquid specimen; a detecting chamber for containing a detecting element; and a through hole for transferring the liquid specimen between the specimen chamber and the detecting chamber. The through hole can be opened or self-sealed. The sealing or opening of the through hole controls whether or not the liquid specimen in the specimen chamber enters the detecting chamber via the through hole. Furthermore, a detection method is provided.Type: ApplicationFiled: March 25, 2011Publication date: February 21, 2013Inventors: Lin Hu, Haipeng Hu, Yinfei Wu
-
Patent number: 8372653Abstract: A molecule identification and quantitation method is provided wherein a mass tag is conjugated to an analyte and the signature ion of the mass tag remains attached to the analyte after tandem mass spectrometry fragmentation (MS-MS or MS2). Rather than losing the signature ion, a mass-balance part of the structure can be lost as a charge neutral group under tandem mass spectrometry fragmentation. The signature ion can be used for quantitation and, upon further fragmentation, can also provide ion-signals characteristic of the analyte and useful in identifying the analyte. In some embodiments, the ion-signals generated from a third mass spectrometry fragmentation (MS3) can be compared with a known mass spectrum, for example, from a look-up table, from a library, or from a database, to provide an unambiguous identification of the analyte.Type: GrantFiled: January 24, 2011Date of Patent: February 12, 2013Assignee: DH Technologies Development Pte. Ltd.Inventors: Subhakar Dey, Subhasish Purkayastha
-
Patent number: 8367415Abstract: A method for detecting a predisposition to breast cancer in a subject is provided. The method includes detecting in a biological sample from the subject one or more polymorphisms in the sequence of CD44 gene. The presence of one or more polymorphisms in the sequence of CD44 gene indicates that the subject has a predisposition for developing breast cancer.Type: GrantFiled: September 8, 2009Date of Patent: February 5, 2013Assignee: University of South CarolinaInventors: Juhua Zhou, Mitzi Nagarkatti, Prakash Nagarkatti
-
Patent number: 8367412Abstract: The present invention provides a technique for crystallizing a desired protein at a high probability; namely, a protein crystallizing agent and a method of crystallizing protein. The present invention also provides a technique for determining the conditions for protein crystallization easily with high efficiency; namely, a method of screening the conditions for protein crystallization and a protein crystallization screening reagent. As the protein crystallizing agent, at least one compound selected from the group consisting of a basic amino acid, acidic amino acid, ester derivative of amino acid and amide derivative of amino acid is used, or at least one of these compounds is used in combination with another protein crystallizing agent.Type: GrantFiled: September 19, 2007Date of Patent: February 5, 2013Assignee: Kwansei Gakuin Educational FoundationInventors: Hiroshi Yamaguchi, Len Ito
-
Patent number: 8361806Abstract: The invention provides, inter alia, methods, devices and reagents for the preparation of native and non-denatured biomolecules using solid-phase extraction channels. The invention is particularly suited for the purification, concentration and/or analysis of protein analytes. The invention further provides, inter alia, methods, devices and reagents for the purification, concentration and/or analysis of multi-protein complexes.Type: GrantFiled: January 6, 2011Date of Patent: January 29, 2013Assignee: PhyNexus, Inc.Inventors: Douglas T. Gjerde, Christopher T. Hanna
-
Publication number: 20130017562Abstract: An assay for identifying an individual having or at risk of developing vascular calcification, said assay comprising obtaining a blood sample from an individual and measuring the level of a vesicular compound in a matrix vesicle present in the blood sample from said individual; wherein an increased level of said compound indicates an individual at risk of developing vascular calcification.Type: ApplicationFiled: February 11, 2011Publication date: January 17, 2013Applicant: KING'S COLLEGE LONDONInventors: Catherine M. Shanahan, Alexander N. Kapustin
-
Publication number: 20130011925Abstract: Embodiments of the present invention are directed to articles of manufacture, devices, methods and apparatus for performing liquid chromatography featuring a chromatographic sorbent having one or more pentafluorophenyl groups, wherein said one or more pentafluorophenyl groups are a bonded phase on a sorbent selected from the group comprising silica, organic polymers or hybrid organic diene material and said pentafluorophenyl groups are in a mono-, bi-, and tridentate forms.Type: ApplicationFiled: July 10, 2012Publication date: January 10, 2013Applicant: Waters CorporationInventors: Martin Gilar, Ying-Qing Yu, Jennifer Fournier, John E. O'Gara
-
Patent number: 8349569Abstract: A method for measuring a fibronectin fragment which is easy to handle and has excellent measuring accuracy, specificity and reproducibility is provided. An anti-fibronectin fragment monoclonal antibody which reacts with a human fibronectin fragment but does not react with human fibronectin, a measuring reagent containing the monoclonal antibody, a method for measuring a fibronectin fragment which uses the monoclonal antibody and a hybridoma which produces the monoclonal antibody are provided.Type: GrantFiled: March 31, 2010Date of Patent: January 8, 2013Assignee: Takara Bio Inc.Inventors: Chika Kato, Yuka Sano, Kyoko Kamihagi, Ikunoshin Kato
-
Publication number: 20130004940Abstract: A device for detecting an analyte in a sample is provided, which comprises: a collecting chamber containing an opening for collecting a liquid sample; a detecting element for detecting an analyte in the liquid sample; and a lid for covering the opening of the collecting chamber. The device further comprises an indicating device thereon to indicate whether or not the lid covers at an appointed position. The operation of the device is very simple.Type: ApplicationFiled: November 23, 2010Publication date: January 3, 2013Inventors: Haipeng Hu, Jianfeng Wang
-
Publication number: 20120295273Abstract: The present invention provides methods of evaluating a glycoprotein preparation for the absence, presence or amount of an N-acetylhexosamine glycan, e.g., an N-acetylglucosamine glycan.Type: ApplicationFiled: March 12, 2012Publication date: November 22, 2012Inventors: Nathaniel J. Washburn, Enrique Arevalo, Kevin Millea, Carlos J. Bosques, Jay Duffner, Brian E. Collins
-
Publication number: 20120288852Abstract: A sensitive and specific method of detecting chemical species, viruses and microorganisms is presented to improve performance of molecular-recognition-based assays utilizing particles decorated with molecular recognition agents such as antibodies and DNA probes, and observing analyte-dependent changes in the response of the particles to forces such as magnetic or gravitational forces or Brownian thermal fluctuations.Type: ApplicationFiled: January 15, 2011Publication date: November 15, 2012Inventors: Richard Willson, Paul Ruchhoeft
-
Patent number: 8304250Abstract: A multi-dimensional chromatographic method for the separation of N-glycans. The method comprises providing a glycan preparation that includes at least one negatively charged N-glycan. The glycan preparation is then separated by anion-exchange chromatography and at least one secondary chromatographic technique.Type: GrantFiled: April 15, 2008Date of Patent: November 6, 2012Assignee: Momenta Pharmaceuticals, Inc.Inventors: Ian Christopher Parsons, Ting Zheng, Nur Sibel Gunay, Carlos J. Bosques
-
Publication number: 20120270255Abstract: The disclosure relates to the development of improved methods for quantifying antigen in a vaccine composition in the absence of available antigen standards. More specifically, the disclosure provides fast and robust methods of separating antigens from vaccine compositions, comprising the steps of solubilizing antigen without detergent and without alkylation, using acidification to prevent antigen subtypes from binding again, isolating antigen subtypes with chromatography, and quantifying the eluted antigen with amino acid analysis. The methods of the disclosure are applicable for use with a variety of antigens, thereby providing an improved method in the art of vaccine manufacturing to date.Type: ApplicationFiled: April 18, 2012Publication date: October 25, 2012Applicants: BAXTER HEALTHCARE S.A., BAXTER INTERNATIONAL INC.Inventors: Michael Graninger, Martin Kaliwoda
-
Patent number: 8278414Abstract: The present invention concerns a novel retinoic acid regulated gene whose expression product displays useful morphogenic/mitogenic properties. The present invention further concerns an isolated nucleic acid of SEQ ID NO:1 encoding a retinoic acid regulated expression product having an amino acid sequence of SEQ ID NO:2.Type: GrantFiled: December 19, 2008Date of Patent: October 2, 2012Assignee: The Hong Kong University of Science and TechnologyInventors: Nancy Yuk Yu Ip, William M. W. Cheung
-
Patent number: 8278109Abstract: The present invention related to a pregnancy test device that can selectively detect hyperglycosylated human chorionic gonadotropin (hCG-H) in a liquid sample. The sample can be deposited on a proximal portion of the device for transport to a distal portion of the device. The device can include a release medium formed of a first material and including a detectable label thereon and a capture medium, including a capture site, in fluid communication with the release medium and formed of a second, different material. At least one of the release medium and the capture medium includes a binding member that exhibits a moderate to high affinity for hCG-H and is selectively or preferentially reactive with hCG-H.Type: GrantFiled: February 12, 2010Date of Patent: October 2, 2012Assignee: Church & Dwight Co., Inc.Inventors: Albert R. Nazareth, Timothy Snowden
-
Publication number: 20120246745Abstract: The present invention provides an animal toxicity model that can be used to screen agents that may cause or increase the occurrence of a developmental defect. The invention also provides methods and compositions for creating such an animal toxicity model, as well as methods and kits for using these animal models.Type: ApplicationFiled: June 6, 2012Publication date: September 27, 2012Applicant: Numira Biosciences, Inc.Inventor: Anthony F. PURCHIO
-
Patent number: 8257981Abstract: Novel chemical compounds, with application in fluorometric analytical methods, for qualitative and quantitative determination of biomolecules. The aim of the invention is to identify and prove the suitability of such compounds. Said aim is achieved with compounds of formula (1) where R1 is an antenna function, R2 is a chelate forming agent, containing a coordinated lanthanide(III)ion, X is —OH or a group with affinity for the biomolecule, bonded to a carboxylate group of the chelate forming agent by means of an amide bond and Y is —H or a group with affinity for the biomolecule, coupled to the antenna function.Type: GrantFiled: April 30, 2005Date of Patent: September 4, 2012Assignee: Sensient Imaging Technologies GmbHInventors: Jörg Marx, Frank Schumer, Regina Lischewski, Kornelia Zeckert, Hans-Joachim Böhme, Horst Hennig
-
Publication number: 20120142116Abstract: An object of the present invention is to provide a co-crystal of a Ras polypeptide which adopts a conformation having a pocket on the molecular surface of Ras and GTP or a GTP analog, a production method for the crystal, and a screening method for a Ras function inhibitor based on information about the conformation obtained by X-ray crystallographic analysis using the crystal. The object is achieved by focusing on a mutation which adopts a conformation having a pocket on the molecular surface of Ras, acquiring a mutant Ras polypeptide having introduced therein such mutation, producing a co-crystal of the mutant Ras polypeptide and a GTP analog, and further subjecting the co-crystal to X-ray crystallographic analysis to acquire structural information about the conformation including information about the structure surrounding the pocket.Type: ApplicationFiled: July 13, 2010Publication date: June 7, 2012Applicants: JAPAN SYNCHROTRON RADIATION RESEARCH INSTITUTE, NATIONAL UNIVERSITY CORPORATION KOBE UNIVERSITYInventors: Tohru Kataoka, Fumi Shima, Atsuo Tamura, Takashi Kumasaka
-
Patent number: 8192996Abstract: A method for storing a tetrazolium compound stably is provided. The tetrazolium compound is stored in the presence of sodium azide. The tetrazolium compound (A) and the sodium azide (B) are present at a ratio (A:B) in the range from 1:0.02 to 1:6.2. Furthermore, when the tetrazolium compound is stored as a solution, the concentration of the sodium azide is in the range from 0.08 to 3.2 mmol/L and the concentration of the tetrazolium compound is in the range from 0.5 to 8 mmol/L. As the tetrazolium compound, it is preferable to use 2-(4-iodophenyl)-3-(2,4-dinitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium salt.Type: GrantFiled: April 1, 2009Date of Patent: June 5, 2012Assignee: Arkray, Inc.Inventors: Kaori Ishimaru, Satoshi Yonehara
-
Detection of lysophosphatidylcholine for prognosis or diagnosis of a systemic inflammatory condition
Patent number: 8183050Abstract: The present invention provides methods and compositions useful for the diagnosis or prognosis of a systemic inflammatory condition such as sepsis.Type: GrantFiled: September 28, 2006Date of Patent: May 22, 2012Assignee: Becton, Dickinson and CompanyInventors: Song Shi, Thomas Gentle, Richard Moore -
Patent number: 8173436Abstract: Systems and methods for detecting the presence of biomolecules in a sample using biosensors that incorporate resonators which have functionalized surfaces for reacting with target biomolecules. In one embodiment, a device includes a piezoelectric resonator having a functionalized surface configured to react with target molecules, thereby changing the mass and/or charge of the resonator which consequently changes the frequency response of the resonator. The resonator's frequency response after exposure to a sample is compared to a reference, such as the frequency response before exposure to the sample, a stored baseline frequency response or a control resonator's frequency response.Type: GrantFiled: December 14, 2010Date of Patent: May 8, 2012Assignee: Intel CorporationInventors: Yuegang Zhang, Andrew Berlin, Qing Ma, Li-Peng Wang, Valluri Rao, Mineo Yamakawa
-
Publication number: 20120094858Abstract: The invention relates to a method of diagnosing or monitoring bipolar disorders, in particular bipolar I and bipolar II disorders, such as manic psychosis.Type: ApplicationFiled: April 16, 2010Publication date: April 19, 2012Applicant: Psynova Neurotech Ltd.Inventors: Sabine Bahn, Emanuel Schwarz, Marlis Huebner
-
Patent number: 8158436Abstract: The invention provides methods and apparatus for characterizing complex polymeric mixture of interest. Candidate solutions are eliminated from a solution space using one or more experimental measurements of a polymeric mixture of interest. The elimination step can be repeated one or more times using different experimental measurements produced by various chemical and physical protocols, so that the remaining candidate solutions converge to describe the actual polymeric mixture under investigation. Once the composition of the complex polymeric mixture has been characterized, the information thus generated can be used to facilitate, for example, the manufacture of a bio-equivalent of the complex polymeric mixture.Type: GrantFiled: September 3, 2010Date of Patent: April 17, 2012Assignee: Momenta Pharmaceuticals, Inc.Inventor: Sasisekharan Raguram
-
Patent number: 8143066Abstract: A method (100) for analyzing chemicals includes fractionating a complex sample into at least two sample portions that each includes portions of two polypeptides though in different concentration ratios, digesting and performing LC/MS on each of the sample portions (110, and associating precursor ions observed via LC/MS with their corresponding polypeptide in response to LC/MS provided intensity data (170). A set of precursor ions that has substantially similar intensity ratios in both sample portions is determined to be associated with the same polypeptide.Type: GrantFiled: June 5, 2006Date of Patent: March 27, 2012Assignee: Waters Technologies CorporationInventors: Marc V. Gorenstein, Scott J. Geromanos, Jeffrey Cruz Silva, Guo-Zhong Li
-
Patent number: 8105838Abstract: A method (100) for performing chemical analyses includes digesting a reference sample to obtain precursors associated with a peptide in the sample (110), separating the precursors to determine values associated with retention times of the separated precursors (120), ionizing the separated precursors to form precursor ions (130), mass analyzing the precursor ions to determine values associated with mass and with ion intensity (140), and storing a <fcfile of the polypeptide defined by the determined values (150). A subject sample is analyzed (160), and the polypeptide is detected in the subject sample in response to a match between subject-sample and profile values. An apparatus (900) for performing chemical analyses includes a chromatography module (904), a mass-spectrometry module (912), and a computer module (926).Type: GrantFiled: June 5, 2006Date of Patent: January 31, 2012Assignee: Waters Technologies CorporationInventors: Marc V. Gorenstein, Scott Geromanos, Jeffrey Cruz Silva, Guo-Zhong Li
-
Patent number: 8076156Abstract: A glucosamine sample is analyzed using an isotope ratio mass spectrometer to determine whether the glucosamine sample is corn-based, e.g., vegetable-based, as opposed to shellfish-based. The isotope ratio mass spectrometer yields an isotopic value for ? 13C that is compared to a reference isotope value for corn, typically about ?12.0%. If there is substantial agreement between the two ratios, then it is known with reasonable certainty that the glucosamine origin is corn and is thus vegetable-based. If there is substantial disagreement between the two ratios, it is known that the glucosamine is not corn-based and is likely shellfish-based. In this fashion, end consumers who cannot consume shellfish-based glucosamine, for reasons of religion or allergy, can purchase glucosamine with greater confidence.Type: GrantFiled: May 29, 2009Date of Patent: December 13, 2011Assignee: Ethical Naturals, Inc.Inventor: Lora Xiong
-
Publication number: 20110287559Abstract: A method of characterizing glycans attached to glycoproteins is disclosed herein. The method comprises a first step of immobilizing the glycoproteins on colloidal particles forming glycoprotein/colloidal particles. The glycans on the glycoproteins may then be characterized, for example the composition and/or structure of glycans may be characterized or the glycans attached to proteins may be identified. Characterization may be accomplished by either binding the glycoprotein/colloidal particles with one or more binding agents and assessing the aggregation of the glycoprotein/colloidal particles or by cleaving glycans from the glycoprotein/colloidal particles with a cleaving agent and analyzing the glycans.Type: ApplicationFiled: May 20, 2011Publication date: November 24, 2011Applicant: National Institute of Standards and TechnologyInventors: Rebecca A. Zangmeister, Germarie Sanchez-Pomales, Todd A. Morris, Michael J. Tarlov
-
Publication number: 20110287413Abstract: A microfluidic system comprising a 1st reaction zone, a 2nd reaction zone, a reagent delivery channel configured to deliver one or more reagents to the 1st reaction zone, a waste channel to remove waste from the 2nd reaction zone, a 1st sample delivery channel configured to deliver a sample to the 1st reaction zone and a 2nd sample delivery channel configured to deliver a sample to the 2nd reaction zone; wherein the microfluidic system comprises a means for retaining one or more reagents in each reaction zone; and wherein the 1st reaction zone and 2nd reaction zone are connected in series by a reaction zone channel.Type: ApplicationFiled: August 12, 2009Publication date: November 24, 2011Applicant: ITI SCOTLAND LIMITEDInventors: Julien Chapron, Lidia Prieto-Lafuente
-
Patent number: 8062896Abstract: The present invention relates to the use of cardiac hormones, particularly natriuretic peptides, for diagnosing the cardiovascular risk of a patient who is a candidate for administration of a cox-2-inhibiting compound, in particular an NSAID, selective cox-2 inhibitor, or steroid. More particularly, the present invention relates to the use of cardiac hormones, particularly natriuretic peptides, for diagnosing the cardiovascular risk of a patient who is a candidate for administration of a selective cox-2 inhibitor and further provides methods for diagnosing the risk of a patient to suffer from a cardiovascular complication as a consequence of administration of a cox-2 inhibiting compound.Type: GrantFiled: September 2, 2008Date of Patent: November 22, 2011Assignee: Roche Diagnostics Operations, Inc.Inventor: Eberhard Spanuth
-
Patent number: 8044195Abstract: This invention provides cross-linked glycopeptide—cephalosporin compounds and pharmaceutically acceptable salts thereof which are useful as antibiotics. This invention also provides pharmaceutical compositions containing such compounds; methods for treating bacterial infections in a mammal using such compounds; and processes and intermediates useful for preparing such compounds.Type: GrantFiled: April 13, 2010Date of Patent: October 25, 2011Assignee: Theravance, Inc.Inventor: Daniel D. Long
-
Patent number: RE43795Abstract: The present invention provides a method of pretreating a sample containing a glycated amine as an analyte, thereby enabling highly reliable measurement of a glycated amine. A glycated amino acid in the sample is degraded by causing a fructosyl amino acid oxidase (FAOD) to act thereon, and thereafter, a FAOD further is caused to act on the glycated amine as the analyte in the sample to cause a redox reaction. The amount of the glycated amine is determined by measuring the redox reaction. The substrate specificity of the FAOD caused to act on the glycated amino acid may be either the same as or different from that of the FAOD caused to act on the glycated amine. When using the same FAOD, a FAOD is caused to act on the glycated amino acid to degrade it, and thereafter, the sample is treated with a protease to inactivate the FAOD and also to degrade the glycated amine.Type: GrantFiled: October 9, 2002Date of Patent: November 6, 2012Assignee: ARKRAY, Inc.Inventors: Satoshi Yonehara, Tsuguki Komori